Medication Assisted Treatment of Opioid Use Disorders: Progress and Challenges

January 12, 2016

Loading Events
  • This event has passed.
Watch Now View Presentation Slides

Presenter(s): Nora Volkow, MD, Director, National Institute on Drug Abuse

NOTE:  This webinar was rescheduled from September 29, 2015 when it was cancelled due to technical difficulties. 

Webinar Description:
For decades, medication assisted treatment for opioid use disorders has shown enormous potential for saving lives. When prescribed and monitored properly, medications such as methadone, buprenorphine, and naltrexone are safe and cost-effective components of opioid use disorder treatment that can improve lives, reduce the risk of overdose, increase patient retention, and decrease drug use, infectious disease transmission, and criminal activity. Despite their potential for positive outcomes, however, medication-assisted therapies are still markedly underutilized for a variety of reasons including inadequate provider education and misunderstandings about addiction medications by the public, health care providers, insurers, and patients. One common, long-held, stigma-generating misperception, for example, is that medication-assisted therapies merely replace one substance use disorder for another.

The skyrocketing abuse of both prescription opioids and heroin in recent years dramatically amplifies the urgency for increased access to and improved utilization of these valuable treatment strategies.

This webinar provided recent trends in opiate overdose deaths, opiate abuse, and opioid use disorder treatment needs as well as research efforts currently underway to develop improved long-acting medications and vaccines for opiate use disorder. The importance of the medical community’s engagement and participation in medication assisted treatment was discussed, as well as their critical role in ensuring the successful translation and ultimate adoption of research discoveries into clinical practice.

Accreditation:
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation:  
The APA designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to obtain your CME Credit/Certificate of Completion:
CME Credit Certificates or Certificates of Completion are available to those who complete an evaluation. Please follow the instructions below to obtain your certificate though the APA Learning Center:

To claim credit for the archived version through the APA Learning Center, please do the following:

    1. Go to http://apapsy.ch/MAT-Progress-and-Challenges-Archive
    2. Login to your existing APA account or create a new account if you don’t already have one.
    3. Click “Access Activity.”
    4. Select your certificate type and confirm your choice via the pop-up window (Note: You may need to disable pop-up blockers).
    5. Review the Activity Overview and CE Information sections.
    6. Click “Purchase.” This course is free, but you must still complete the checkout process.
    7. From your order confirmation page, select “Access Course.”
    8. Complete the View Content, Quiz, and Evaluation sections.
    9. Select and Save the number of credits on the Certificate section and review your certificate.

Details

Date:
January 12, 2016
Time:
12:00 pm - 1:00 pm
Event Category:

Other

Presenter
Nora Volkow, MD
Presenter Details
Director, National Institute on Drug Abuse
Time Zone
ET